Washington [US], November 21 (ANI): According to a study published in JAMA Network Open, the population-wide screening for genetic variants linked to hereditary breast and ovarian cancer may be cost-effective in women between the ages of 20 and 35.
Washington [US], November 16 (ANI): Population-wide screening for genetic variants linked to hereditary breast and ovarian cancer may be cost-effective in women between the ages of 20 and 35, according to a study.